Lv44
520 积分 2023-05-06 加入
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins
6小时前
待确认
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
1天前
待确认
Breaking the therapeutic ceiling in drug development in ulcerative colitis
2天前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
3天前
已完结
World-first therapy using donor cells sends autoimmune diseases into remission
21天前
已完结
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
25天前
已完结
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies
25天前
已完结
Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic
25天前
已完结
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers
29天前
已完结
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
1个月前
已完结
皖公网安备34019202002308
